Skip to content
Company Analysis

Medpace Holdings, Inc. MEDP

A comprehensive view of key metrics, scores, and financial health for Medpace Holdings, Inc.

Overview of Medpace Holdings, Inc.

MEDP NMS
Healthcare Diagnostics & Research Framework: Medical Devices & Diagnostics Large Cap
Medpace Holdings, Inc. (MEDP), is a Large Cap company, in the Diagnostics & Research industry, last closed at $467.34, about 66.9% overvalued vs fair value, +55.3% 1Y return, placing in the top 10% of its sector.
Metrics Rev Growth 20.0% ROE 70.2% Gross Margin 30.1%
USD 467.34
-1.63%
(Delayed)
• Vol 90d: 61.8%
52-Week Range
Market Cap
$13.57B
Enterprise Value
$13.18B
Overall Score
View breakdown
Overall
Growth
Fair
Profitability
Excellent
Health
Fair
Efficiency
Good
Valuation
Fair
Growth
Fair
Profitability
Excellent
Health
Fair
Efficiency
Good
Valuation
Fair
Completeness: 82%
Confidence: 50%
Updated: Mar 8
Top Beats

Quick Facts

Website https://www.medpace.com
HQ Cincinnati, OH
Employees 6,200
Fiscal year Dec 31

Next Events

Earnings Jul 20 Estimated

Fair Value Snapshot

Bear Base Bull
$138
$155
$173
Current: $467.34 -67% vs base

Engine Room Money Flow™

Large Cap

Medical Devices & Diagnostics - Where revenue goes and how value is created

Flow Steps
Total Revenue
$2.5B
20%%
Gross Profit
$760.6M
15.9%%
Operating Income (GAAP)
$534.9M
19.7%%
EBITDA
$563.1M
18.3%%
Money Flow Bridge
Flow Direction: Money moves from left to right
Components: Breakdown shows composition of each stage
Industry-Specific: Medical Devices & Diagnostics

Quality & Reliability Indicators

Gross Margin
30.1%
Poor

Gross Profit / Revenue — primary moat signal for MedTech. ≥65% indicates IP-protected consumables with strong pricing power.

Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium

Where It Leaks

Cash Flow Health healthy
Strong cash conversion with minimal leakage across profit-to-cash-to-value chain.
0
Active Leaks
0/0
Improving
0
High Impact
0
Critical
Moat Analysis Medical Devices & Diagnostics

Competitive Advantage Assessment

Evaluating Medpace Holdings, Inc.'s durable competitive advantages across 6 defense dimensions

Overall Moat Strength
67
/100
Moderate
Scores based on quantitative metrics and qualitative factors

Upgrade to unlock interactive defense details

Premium access

Unlock full defense analysis

Get key signals, strengths, and risks for every moat dimension.

Upgrade to Premium Unlock all moat defenses and evidence.

Pricing Power & Consumable Moat

Developing
46
Premium
Unlock full defense details

See key signals plus strengths and risks for this moat dimension.

Upgrade for full defense analysis Premium-only evidence and insights.
For informational purposes only. Not investment advice.

Trade-Off Ledger™

Where management spends the performance budget - Growth, Profitability, or Safety

Generic Industrial / Default vs Industry Peers 92% Coverage
Trade-Off Triangle Visualization A ternary plot showing MEDP's balance between Growth (34.2%), Profitability (40.3%), and Safety (25.5%). Growth 34% Safety 26% Profitability 40%

Click axes to expand details. Marker shows current allocation.

3-Year Trend Analysis Locked
Upgrade to unlock the full 3-year trend analysis and deltas.

Growth

72th percentile vs peers
73
Key Signals
Rev Growth YoY 20.0% 77p Revenue CAGR 3Y 20.1% 75p EPS Growth YoY 42.2% 63p
Strengths
  • Interest Coverage Ratio in top 20% of peers (690.22, 98th percentile)
  • Superior capital returns - 3 return metrics above peer median
  • Growth above peer median with strong metric coverage (75%)
  • ROIC in top 20% of peers (96.7%, 95th percentile)
Risks

No significant risks identified for this axis.

Profitability

86th percentile vs peers
86
Key Signals
Strengths
Risks
Premium
Unlock full Profitability drilldowns

See the signal-level drivers and insights behind this axis. Upgrade to reveal the full Trade-Off Ledger.

Upgrade Now

Safety

54th percentile vs peers
55
Key Signals
Strengths
Safety drilldowns are available to premium members.

Two Futures

Scenario-based fair value ranges for Medpace Holdings, Inc..

Loading valuation model...
Unable to Compute Fair Value

This company cannot be valued using standard models.

What this means: The Scenario Theatre requires financial data (revenue, cash flow, shares outstanding) to calculate fair value estimates. This data may be unavailable for:

  • Recently listed companies (IPOs, SPACs)
  • Shell companies or holding companies
  • Companies that haven't filed recent financials
  • Foreign companies with limited data coverage
X.X%
X%XX%
X.X%
-XX%XX%
XX.X%
-XX%XX%
Adjust the sliders above to explore different valuation scenarios.
Unlock Premium
Reveal the full Scenario Theatre
See live sliders, narratives, and full Bear/Base/Bull outcomes.
Upgrade Now
Bear
-
- - -
- upside
-
Base
$154.51
- - -
-66.9% vs current
Snapshot base estimate
Bull
-
- - -
- upside
-
Fair Value Range Current: $-
$- $- $-
Actions & Info
Send Feedback
Please select a category.
0/1000